A Phase 1 Study to Evaluate the Safety and Target Engagement of EXL01 in the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Mild to Moderate Crohn's Disease

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502241-99-00

Acronym

EXL01-CD-001

Enrollment

Registered

2023-08-07

Start date

2023-03-20

Completion date

2024-05-28

Last updated

2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026